These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8761586)

  • 21. Blindness following visceral leishmaniasis: a neglected post-kala-azar complication.
    Khalil EA; Musa AM; Younis BM; Elfaki ME; Zijlstra EE; Elhassan AM
    Trop Doct; 2011 Jul; 41(3):139-40. PubMed ID: 21676981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Post-kala-azar dermal leishmaniasis in HIV-coinfected individuals: problems in diagnosis and treatment.
    Ramesh V; Avishek K; Salotra P
    Int J Dermatol; 2015 Jan; 54(1):116-20. PubMed ID: 25209701
    [No Abstract]   [Full Text] [Related]  

  • 23. Endemic kala-azar in eastern Sudan: a longitudinal study on the incidence of clinical and subclinical infection and post-kala-azar dermal leishmaniasis.
    Zijlstra EE; el-Hassan AM; Ismael A; Ghalib HW
    Am J Trop Med Hyg; 1994 Dec; 51(6):826-36. PubMed ID: 7810819
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Post-Kala-Azar Dermal Leishmaniasis.
    Sharma A; Bishnoi A; Parsad D
    Am J Trop Med Hyg; 2024 Oct; 111(4):710-712. PubMed ID: 39043164
    [No Abstract]   [Full Text] [Related]  

  • 25. Post-Kala-Azar Dermal Leishmaniasis Without Previous History of Visceral Leishmaniasis.
    Hasnain G; Shomik MS; Ghosh P; Rashid MO; Hossain S; Hamano S; Mondal D
    Am J Trop Med Hyg; 2016 Dec; 95(6):1383-1385. PubMed ID: 27672208
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Post-kala-azar dermal leishmaniasis (PKDL), HIV and pulmonary tuberculosis.
    Das VN; Pandey K; Verma N; Bimal S; Lal CS; Singh D; Das P
    Natl Med J India; 2010; 23(2):88-9. PubMed ID: 20925205
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Post-kala-azar dermal Leishmaniasis and uveitis in an HIV-positive patient.
    Ramos A; Cruz I; Muñez E; Salas C; Fernández A; Alvarez-Espejo T
    Infection; 2008 Mar; 36(2):184-6. PubMed ID: 18327683
    [No Abstract]   [Full Text] [Related]  

  • 28. Oral miltefosine for Indian post-kala-azar dermal leishmaniasis: a randomised trial.
    Sundar S; Sinha P; Jha TK; Chakravarty J; Rai M; Kumar N; Pandey K; Narain MK; Verma N; Das VN; Das P; Berman J; Arana B
    Trop Med Int Health; 2013 Jan; 18(1):96-100. PubMed ID: 23136856
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Insights into the possible role of IFNG and IFNGR1 in Kala-azar and Post Kala-azar Dermal Leishmaniasis in Sudanese patients.
    Salih MA; Fakiola M; Abdelraheem MH; Younis BM; Musa AM; ElHassan AM; Blackwell JM; Ibrahim ME; Mohamed HS
    BMC Infect Dis; 2014 Dec; 14():662. PubMed ID: 25466928
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Post-kala-azar dermal leishmaniasis and leprosy: case report and literature review.
    Trindade MA; Silva LL; Braz LM; Amato VS; Naafs B; Sotto MN
    BMC Infect Dis; 2015 Nov; 15():543. PubMed ID: 26592919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
    Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
    Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypokalaemia-induced rhabdomyolysis after treatment of post-Kala-azar dermal Leishmaniasis (PKDL) with high-dose AmBisome in Bangladesh-a case report.
    Marking U; den Boer M; Das AK; Ahmed EM; Rollason V; Ahmed BN; Davidson RN; Ritmeijer K
    PLoS Negl Trop Dis; 2014 Jun; 8(6):e2864. PubMed ID: 24922279
    [No Abstract]   [Full Text] [Related]  

  • 33. [Histopathological skin changes after kala-azar: post-kala azar dermal leishmaniasis].
    MAJUMDAR TD
    Arch Klin Exp Dermatol; 1956; 203(5):483-502. PubMed ID: 13382178
    [No Abstract]   [Full Text] [Related]  

  • 34. Cure of antimony-unresponsive Indian post-kala-azar dermal leishmaniasis with oral miltefosine.
    Sundar S; Kumar K; Chakravarty J; Agrawal D; Agrawal S; Chhabra A; Singh V
    Trans R Soc Trop Med Hyg; 2006 Jul; 100(7):698-700. PubMed ID: 16325873
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Apparently successful treatment of two cases of post kala-azar dermal leishmaniasis with liposomal amphotericin B.
    Hashim FA; Khalil EA; Ismail A; el Hassan AM
    Trans R Soc Trop Med Hyg; 1995; 89(4):440. PubMed ID: 7570893
    [No Abstract]   [Full Text] [Related]  

  • 36. Post kala azar dermal leishmaniasis in Sudan.
    Kordofani YM; Nour YT; El-Hassan AM; Shalayel MH
    East Mediterr Health J; 2001 Nov; 7(6):1061-4. PubMed ID: 15332749
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Efficacy of ketoconazole in post-kala-azar dermal leishmaniasis.
    Ramesh V; Saxena U; Misra RS
    Arch Dermatol; 1992 Mar; 128(3):411-2. PubMed ID: 1550382
    [No Abstract]   [Full Text] [Related]  

  • 38. Chronic Arsenic Exposure and Risk of Post Kala-azar Dermal Leishmaniasis Development in India: A Retrospective Cohort Study.
    Das S; Mandal R; Rabidas VN; Verma N; Pandey K; Ghosh AK; Kesari S; Kumar A; Purkait B; Lal CS; Das P
    PLoS Negl Trop Dis; 2016 Oct; 10(10):e0005060. PubMed ID: 27776123
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Remission of localized cutaneous leishmaniasis in a HIV-positive patient using systemic terbinafine.
    González-Rupérez J; Javaloyas de Morlius M; Moreno Carazo A
    Dermatology; 1997; 194(1):85-6. PubMed ID: 9031802
    [No Abstract]   [Full Text] [Related]  

  • 40. Post kala-azar dermal leishmaniasis: macular variety.
    Das A; Sarkar TK
    Indian Pediatr; 2014 Dec; 51(12):1041. PubMed ID: 25560172
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.